Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tysabri
Pharma
Sandoz's biosimilar to Biogen's Tysabri hits the US after delay
Biogen has had two years to gear up for the impending launch of Sandoz's biosimilar Tyruko, which earned FDA approval in 2023.
Zoey Becker
Nov 17, 2025 11:12am
Genentech awarded $124M in Cabilly patent dispute with Biogen
Oct 6, 2025 3:37pm
A closer look at pharma’s top patent losses in 2025
Mar 21, 2025 9:00am
The top 10 drugs losing US exclusivity in 2025
Mar 17, 2025 3:00am
Biogen places chips behind 4 new drugs as MS competition mounts
Feb 12, 2025 11:35am
Novartis' knockoff of Biogen's Tysabri is first MS biosim in US
Aug 25, 2023 11:28am
